Protein Interaction Assay May Identify Best NSCLC Candidates for KRAS G12C Inhibitors
Source: Inside Precision Medicine
RAS and RAF protein interaction correlates with KRAS G12C inhibitor response in KRAS G12C-mutated NSCLC, shows a test developed at the Moffitt Cancer Center.
A test that measures the interaction between two proteins, developed by researchers at the Moffitt Cancer Center, could predict which patients with KRAS G12C-mutated non-small-cell-lung cancer (NSCLC) are most likely to respond to KRAS G12C inhibitor… [3486 chars]